Injection site reactions are the most commonly reported skin-related side effects of GLP-1 medications
Adems, creemos que tiene el potencial de establecer un nuevo estndar para el tratamiento de la diabetes tipo 2 en la UE , afirma Mads Krogsgaard Thomsen, vicepresidente ejecutivo y director cientfico de Novo Nordisk
Semaglutide 24 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: A randomised, placebo-controlled phase 2 trial
Ozempic foot So-called Ozempic foot a term for a bony appearance of the feet, with some people also reporting foot pain has been claimed to be a side-effect of GLP-1 medications, but it is not found in patient information leaflets
Medication exclusions are becoming more common The number of formulary exclusions has risen steadily over the last decade
In the treatment of children with an inborn error in the production of transcobalamin II, the binding protein that transports B12 to the cells, serum values are kept at levels of 10 000 pg/ml (about 7 400 pmol/L) without any side-effects
